中教数据库 > World Journal of Stem Cells > 文章详情

Mesenchymal stem cell-derived extracellular vesicles as a new therapeutic strategy for ocular diseases

更新时间:2023-05-28

【摘要】Mesenchymal stem cells(MSCs) have attracted considerable attention for their activity in the treatment of refractory visual disorders. Since MSCs were found to possess the beneficial effects by secreting paracrine factors rather than direct differentiation, MSC-derived extracellular vesicles(EVs) were widely studied in various disease models. MSCs generate abundant EVs, which act as important mediators by exchanging protein and genetic information between MSCs and target cells. It has been confirmed that MSC-derived EVs possess unique antiinflammatory, anti-apoptotic, tissue repairing, neuroprotective, and immunomodulatory properties, similar to their parent cells. Upon intravitreal injection, MSC-derived EVs rapidly diffuse through the retina to alleviate retinal injury or inflammation. Due to possible risks associated with MSC transplantation, such as vitreous opacity and pathological proliferation, EVs appear to be a better choice for intravitreal injection. Small size EVs can pass through biological barriers easily and their contents can be modified genetically for optimal therapeutic effect. Hence, currently, they are also explored for the possibility of serving as drug delivery vehicles. In the current review, we describe the characteristics of MSC-derived EVs briefly, comprehensively summarize their biological functions in ocular diseases, and discuss their potential applications in clinical settings.

【关键词】

310 2页 免费

发表评论

登录后发表评论 (已发布 0条)

点亮你的头像 秀出你的观点

0/500
以上留言仅代表用户个人观点,不代表中教立场
相关文献

推荐期刊

Copyright © 2013-2016 ZJHJ Corporation,All Rights Reserved

京ICP备2021021570号-13

京公网安备 11011102000866号